期刊文献+

心理干预合并艾司西酞普兰治疗重度抑郁症作用研究 被引量:2

Efficacy study of psychological intervention combined with escitalopram in the treatment of severe depression
下载PDF
导出
摘要 目的:探讨心理干预联合艾司西酞普兰治疗重度抑郁症的疗效和安全性。方法:将120例患者随机分为对照组和研究组,对照组给予艾司西酞普兰治疗,研究组在艾司西酞普兰治疗的同时进行针对性的心理干预,疗程均为8周,治疗前及治疗后第1、2、4、6、8周末采用汉密尔顿抑郁量表(HAMD)进行疗效评定,用症状量表(TESS)评定用药不良反应。治疗前、后分别对患者行血常规、肝功能、肾功能、心电图检查以评价安全性。结果:研究组治疗后第2周末起HAMD量表评分较治疗前显著下降(P<0.05,P<0.01),对照组治疗后第4周末起HAMD量表评分较治疗前显著下降(P<0.05,P<0.01)。治疗后第2、4、6周末,两组间比较有显著性差异(P<0.05),治疗后第8周末,两组间比较无显著性差异(P>0.05)。两组TESS评分比较差异无统计学意义(P>0.05)。结论:心理干预联合艾司西酞普兰能显著提高重度抑郁症的临床疗效,安全性高,依从性好。 Objective: To investigate the efficacy and safety of psychological intervention combined with Escitalopram in the treatment of severe depression. Methods:120 patients were randomly divided into control group and study group, the control group were given Escitalopram treatment, at the same time in the study group at Escitalopram treatment was provided along with psychological intervention, treatment was carried for 8 weeks, Hamilton Depression Scale (HAMD) was used to assess the efficacy before treatment and 1, 2, 4, 6, 8 after treatment, symptom checklist (TESS) evaluation of drug adverse reaction was also carried in the similar manner. For safety evaluation blood routine test, liver function, kidney function, electrocardiogram was investigated respectively before and after the treatment. Results; HAMD scale score were significantly decreased (P〈0.05, P〈0.01) for the study group after second weeks of treatment and for the control group similar decrease in HAMD Score was seen after fourth weeks of treatment. There was a significant difference between the two groups (P〈0.05) after the treatment of 2, 4, 6 over the weekend but after eighth weeks of treatment there is no significant difference between the two groups (P〉0.05). No statistically significant difference in TESS scores were compared in two groups (P〉0.05). Conclusion psychological intervention combined with Escitalopram can significantly improve the clinical efficacy of severe depression, high safety, and good compliance.
作者 桑艳云
出处 《中医临床研究》 2015年第24期46-48,共3页 Clinical Journal Of Chinese Medicine
关键词 心理干预 艾司西酞普兰 重度抑郁症 抗抑郁药物 Psychological intervention Escitalopram Severe depression Antidepressant drugs
  • 相关文献

参考文献7

二级参考文献29

  • 1金卫东.双相障碍的药物治疗方案与流程[J].国外医学(精神病学分册),2005,32(2):69-73. 被引量:31
  • 2马永春,陈正昕,金卫东.奥卡西平在精神科的临床应用[J].临床精神医学杂志,2006,16(5):316-317. 被引量:12
  • 3中华医学会第一届全国癫痫学术会议.癫痫发作分类法(草案)[J].中华神经精神科杂志,1986,19(4):256-256.
  • 4山东科学技术出版社.CCMD-3中国精神障碍分类与诊断标准-86.
  • 5沈其杰,刘铁榜,张鸿燕.双相障碍防治指南39-40.
  • 6沈鱼邨.精神病学第四版703-705.
  • 7SUPPES T,BENNEHY E B,SWANN A C,et al. Report of texas consensus conference panel on medication treatment of bipolar disorder 2000 [ J ]. J Clin Psychiatry ,2002,63 ( 4 ) : 288.
  • 8GHAEMI S N , BERV D A, KLUGMAN J, et al. Ox- carbazepine treatment of bipolar disorder [ J ]. J Clin Psychiatry ,2003 ,64(8) :943-945.
  • 9BENEDETTI A, LATTANZI L, PINI S , et al. Oxcarba- zepine as add-on treatment in patients with bipolar manic, mixed or depressive episode[J]. JAffect Disord ,2004 ,79 ( 1 ) :273-277.
  • 10Freidel M, Krause E, Kuhn K, et al. Oxcarbazepine in the treat- ment of epilepsy[J].Fortschr Neurol Psyehiatr, 2007,75 (2) 100-106.

共引文献797

同被引文献27

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部